Zuranolone fafety and tolerability in adults with postpartum depression: analyses from SKYLARK, a 50 mg placebo-controlled study
Year: 2024
Type: article
Source: Neuroscience Applied
Authors: S. Meltzer-Brody, L. Shirikjian, K. Laguerre, M. Moseley, S. Li, D. Kile, F. Forrestal, V. Ona, S. Levin, J. Joseph
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W4405636271
